biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BTI:TSXV: Announces $200,000 Non-Brokered Private Placement

<< Previous

Bullboard Posts

Next >>

Comment by MBT123on Jan 29, 2021 5:29pm

133 Views

Post# 32426145

RE:RE:BTI:TSXV: Announces $200,000 Non-Brokered Private Placement

Part-time CEO brokers another head scratching finacing..Just keeping her cell Bill paid for another few months or maybe to pay off a tab at her local beach front watering hole..Does Denali and ther 5b market cap still compare to us raising a whopping $200k? Asking for a friend

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth